# Ergocalciferol Therapy in Calcidiol Deficient, Hemodialysis Patients on Therapeutic Doses of Paricalcitol

> **NCT02011828** · PHASE1 · COMPLETED · sponsor: **University of Utah** · enrollment: 58 (actual)

## Conditions studied

- Inflammation
- Insulin Resistance

## Interventions

- **DRUG:** Ergocalciferol
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02011828
- **Lead sponsor:** University of Utah
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05
- **Primary completion:** 2011-01
- **Final completion:** 2011-01
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2016-08-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02011828

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02011828, "Ergocalciferol Therapy in Calcidiol Deficient, Hemodialysis Patients on Therapeutic Doses of Paricalcitol". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02011828. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*